Techniques: Platelet derived growth factor AB (PDGFAB) and Vidaza azacitidine to reprogram terminally differentiated cells into induced multipotent stem cells f

Drug platforms

TECHNOLOGY: Cell therapy

Reprogramming terminally differentiated cells with PDGFAB and Vidaza azacitidine could help generate induced multipotent stem cells for regenerative therapies. Treatment

Read the full 235 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE